Logos Global Management LP Raises Stake in COMPASS Pathways plc (NASDAQ:CMPS)

Logos Global Management LP increased its position in COMPASS Pathways plc (NASDAQ:CMPS) by 349.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,159,030 shares of the company’s stock after buying an additional 901,050 shares during the period. Logos Global Management LP owned about 1.69% of COMPASS Pathways worth $7,001,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the company. Affinity Asset Advisors LLC purchased a new stake in COMPASS Pathways during the fourth quarter worth approximately $4,812,000. Quest Partners LLC acquired a new stake in COMPASS Pathways in the fourth quarter valued at $33,000. Hennion & Walsh Asset Management Inc. acquired a new stake in shares of COMPASS Pathways during the second quarter worth $664,000. Tidal Investments LLC increased its holdings in shares of COMPASS Pathways by 43.6% in the 1st quarter. Tidal Investments LLC now owns 19,082 shares of the company’s stock worth $159,000 after acquiring an additional 5,795 shares during the period. Finally, Virtu Financial LLC bought a new position in COMPASS Pathways in the 1st quarter valued at about $201,000. Institutional investors and hedge funds own 46.19% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on CMPS. HC Wainwright restated a “buy” rating and set a $120.00 price objective on shares of COMPASS Pathways in a research report on Friday, August 23rd. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of COMPASS Pathways in a research note on Monday, September 9th. Canaccord Genuity Group reduced their price objective on shares of COMPASS Pathways from $50.00 to $48.00 and set a “buy” rating for the company in a research note on Friday, August 2nd. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $23.00 price target on shares of COMPASS Pathways in a research report on Tuesday, September 10th. Six research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $47.40.

COMPASS Pathways Trading Down 3.7 %

Shares of CMPS stock opened at $6.98 on Tuesday. COMPASS Pathways plc has a 12 month low of $5.01 and a 12 month high of $12.75. The company has a quick ratio of 12.03, a current ratio of 12.03 and a debt-to-equity ratio of 0.13. The business’s 50 day moving average is $7.21 and its two-hundred day moving average is $7.75. The company has a market cap of $477.30 million, a PE ratio of -2.95 and a beta of 2.27.

COMPASS Pathways (NASDAQ:CMPS) last announced its earnings results on Thursday, August 1st. The company reported ($0.56) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.53) by ($0.03). During the same period last year, the company earned ($0.62) EPS. Equities analysts predict that COMPASS Pathways plc will post -2.35 EPS for the current year.

COMPASS Pathways Profile

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa.